COMPASS Pathways plc (CMPS) stock

CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 1/30

$9.12−0.18 (-1.94%)

Close on Nov 12, 2026Market cap $1.26BP/E –Yield –

COMPASS Pathways gross margin

Gross margin is gross profit as a percentage of revenue.

COMPASS Pathways has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?